Serous Cystic Tumors of the Pancreas: When to Observe and When to Operate

Zanini, Nicola; Fantini, Lorenzo; Casadei, Riccardo; Pezzilli, Raffaele; Santini, Donatella; Calculli, Lucia; Minni, Francesco

doi:10.1159/000142947

Cited by 10 publications

(9 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Only SCTs can be reliably identified at CT [32]; a probable diagnosis of SCT was formulated in 4 patients. If considering the epidemiology of pancreatic cystic lesions, it should be noted that pseudocysts account for less than 5% of asymptomatic cysts, and true epithelial cysts are rare in the absence of systemic cystic disease [30].…”

Section: Discussionmentioning

confidence: 99%

Estimation of the prevalence of asymptomatic pancreatic cysts in the population of San Marino

et al. 2015

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Estimation of the prevalence of asymptomatic pancreatic cysts in the population of San Marino

et al. 2015

Self Cite

View full text Add to dashboard Cite

“…All mucinous cystic neoplasms are generally considered potentially malignant owing to the risk of an associated cystadenocarcinoma. Serous cystic tumors, on the other hand, are completely benign with no reported recurrence following complete surgical resection [12,13]. …”

Section: Pancreatic Adenocarcinoma: Evolution and Progressionmentioning

confidence: 99%

Current status of molecular markers for early detection of sporadic pancreatic cancer

Chakraborty

Baine

Sasson

et al. 2011

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

View full text Add to dashboard Cite

Pancreatic cancer (PC) is a highly lethal malignancy with near 100% mortality. This is in part due to the fact that most patients present with metastatic or locally advanced disease at the time of diagnosis. Significantly, in nearly 95% of PC patients there is neither an associated family history of PC nor of diseases known to be associated with an increased risk of PC. These groups of patients who comprise the bulk of PC cases are termed as "sporadic PC" in contrast to the familial PC cases that comprise only about 5% of all PCs. Given the insidious onset of the malignancy and its extreme resistance to chemo and radiotherapy, an abundance of research in recent years has focused on identifying biomarkers for the early detection of PC, specifically aiming at the sporadic PC cohort. However, while several studies have established that asymptomatic individuals with a positive family history of PC and those with certain heritable syndromes are candidates for PC screening, the role of screening in identifying sporadic PC is still an unsettled question. The present review attempts to assess this critical question by investigating the recent advances made in molecular markers with potential use in the early diagnosis of sporadic PC-the largest cohort of PC cases worldwide. It also outlines a novel yet simple risk-factor based stratification system that could be potentially employed by clinicians to identify those individuals who at an elevated-risk for the development of sporadic PC and therefore candidates for screening. Keywords diagnosis; PanIN; biomarkers PrologueIt seems that pancreatic cancer (PC) has recently crept further and further into the consciousness of the general public. The news that Luciano Pavarotti, the renowned opera Address for Correspondence: Surinder K. Batra, Ph.D., Department of Biochemistry and Molecular Biology, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, 985870 Nebraska Medical Center, Omaha, NE 68198-5870, U.S.A., Phone: 402-559-5455; Fax: 402-559-6650. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. NIH Public Access Author ManuscriptBiochim Biophys Acta. Author manuscript; available in PMC 2012 January 1. NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript singer and one of the legendary "three tenors" had been diagnosed with PC came as a shock to millions of his followers the world over. A year-and-a-half later, the famous actor and heartthrob, Patrick Swayze, also received the diagnosis of PC and succumbed to his disease in just 19 months. Former United States...

show abstract

“…Surgical resection is generally performed to relieve symptoms, if the SCN is large, or because of the inability to distinguish an SCN from a mucinous neoplasm, which has a greater malignant potential [19]. Resection of all cystic neoplasms of the pancreas has been recommended by some [20,21,22], whereas others have advocated more selective approaches based on individual cases [23,24]. …”

Section: Introductionmentioning

confidence: 99%